ReviewTherapeutics and clinical risk management2022

A Profile of Avelumab Plus Axitinib in the Treatment of Renal Cell Carcinoma.

Manuela Tiako Meyo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.